Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class ASSE: 603707

Announcement on Convening 2024 Annual and Q1 2025 Performance and 2024 Cash Dividend Briefing

· Issued by Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening 2024 Annual and Q1 2025 Performance and 2024 Cash Dividend Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment